PolicyHealth & EducationCardiovascular healthPrint articleCholesterol jab could transform heart disease treatmentMiranda LevySep 3, 2021 – 1.07pmSaveLog in or Subscribe to save articleShareCopy linkCopiedEmailLinkedInTwitterFacebookCopy linkCopiedShare via...Gift this articleSubscribe to gift this articleGift 5 articles to anyone you choose each month when you subscribe.Subscribe nowAlready a subscriber? LoginLondon | British plans to use a “game-changing” drug to lower cholesterol have been hailed by UK Health Secretary Sajid Javid as “a huge step forward in tackling the scourge of heart disease”.The National Institute for Health and Care Excellence this week said twice-yearly injections of the drug inclisiran should first be targeted at people who have already had a heart attack or stroke.Loading...The Telegraph LondonSaveLog in or Subscribe to save articleShareCopy linkCopiedEmailLinkedInTwitterFacebookCopy linkCopiedShare via...Gift this articleSubscribe to gift this articleGift 5 articles to anyone you choose each month when you subscribe.Subscribe nowAlready a subscriber? LoginIntroducing your NewsfeedFollow the topics, people and companies that matter to you.Find out moreRead MoreCardiovascular healthSajid JavidUKUSAMedicineResearchGeneticsLatest In Health & educationFetching latest articlesMost Viewed In PolicyThe Australian Financial Review MagazineThe top whisky you can buy without going on a waiting listMax AllenThe luxury travel trend you probably haven’t consideredThe restaurant that’s turning back the clock (in the best way)BOSS Financial ReviewHow Matt Comyn starts his daySally Patten and Lap PhanFrom stopping thieves in the GFC to running a $1b company, via The StarNew MP Mary Aldred urges business to help women into the LiberalsLife & LeisureWe’ve seen the future, and it’s wearing BirkenstocksJohn DavidsonThe secret world of rare car tradingThis eye-popping new safari resort colours outside the linesRich ListAnnie Cannon-Brookes steps out on her ownYolanda RedrupLuxury home sales take off as Australians get richerPharmacy chain ‘underdog’ takes the fight to Chemist Warehouse
